About the journal
Cancer Control is an open-access journal published by SAGE Publishing in United States, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,650 USD. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 1073-2748 · 1526-2359
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,650 USD
- Articles in DOAJ
- 1222
- Declared review time
- 12 weeks
- Declared peer-review model
- double_blind
- Official website
- https://journals.sagepub.com/home/ccx
Index listings
- DOAJ · 2020-05-27
- MEDLINE · 2000-01-01
- Indexing
- DOAJ · MEDLINE
- APC
- 2,650 USD
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1222
Most recent article
last month
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
2932
Last recorded publication year
2026
h-index
97
i10-index
1147
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-04
- Added to DOAJ
- 2020-05-27
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 97%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Source type
- journal
- NLM unique ID (PubMed)
- 9438457
- Society affiliations
- Moffitt Cancer Center
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Cancer survivorship and care
- Cancer survivorship and care
- Cervical Cancer and HPV Research
- Cervical Cancer and HPV Research
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
Show all subjects (50)
- Lung Cancer Treatments and Mutations
- Breast Cancer Treatment Studies
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Screening and Detection
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Lung Cancer Research Studies
- Diverse Scientific and Economic Studies
- Gastric Cancer Management and Outcomes
- Diverse Scientific and Economic Studies
- Gastric Cancer Management and Outcomes
- Lung Cancer Research Studies
- Esophageal Cancer Research and Treatment
- Esophageal Cancer Research and Treatment
- Palliative Care and End-of-Life Issues
- Palliative Care and End-of-Life Issues
- BRCA gene mutations in cancer
- Cancer Immunotherapy and Biomarkers
- BRCA gene mutations in cancer
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Sarcoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Sarcoma Diagnosis and Treatment
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Cutaneous Melanoma Detection and Management
- Cutaneous Melanoma Detection and Management
Keywords (DOAJ)
- cancer prevention
- cancer detection
- cancer diagnosis
- cancer treatment
- cancer survivorship
- palliative care
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ